Literature DB >> 119799

Hypothalamic-pituitary function in Cushing's disease.

D Le Roith, M S Shapiro, A Gutman, I M Spitz.   

Abstract

Hypothalamic pituitary function was evaluated in seven patients with Cushing's disease. In all subjects there was an absence of GH elevation following hypoglycemia. Three patients demonstrated basal hyperprolactinemia. Six had an intact PRL rise following TRH. However, four patients failed to show PRL elevation with insulin hypoglycemia and six were unresponsive to chlorpromazine. Five patients showed impaired TSH response to TRH. Many of the subjects had low basal LH and FSH levels. Attenuated or absent gonadotropin responses to LHRH were noted in three females. One male demonstrated an exaggerated FSH response to LHRH. These results indicate that multiple abnormalities of anterior pituitary hormone secretion characterize Cushing's disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 119799     DOI: 10.1007/BF03349337

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  HUMAN GROWTH HORMONE. CLINICAL MEASUREMENT, RESPONSE TO HYPOGLYCEMIA AND SUPPRESSION BY CORTICOSTEROIDS.

Authors:  A G FRANTZ; M T RABKIN
Journal:  N Engl J Med       Date:  1964-12-31       Impact factor: 91.245

2.  Effects of glucocorticoids on pituitary hormonal responses to hypoglycemia. Inhibition of prolactin release.

Authors:  G Copinschi; M L'Hermite; R Leclercq; J Golstein; L Vanhaelst; E Virasoro; C Robyn
Journal:  J Clin Endocrinol Metab       Date:  1975-03       Impact factor: 5.958

3.  Intracellular glucopenia causes prolactin release in man.

Authors:  P D Woolf; L A Lee; W Leebaw; D Thompson; U Lilavivathana; R Brodows; R Campbell
Journal:  J Clin Endocrinol Metab       Date:  1977-09       Impact factor: 5.958

4.  Response to synthetic thyrotropin-releasing hormone in man.

Authors:  J M Hershman; J A Pittman
Journal:  J Clin Endocrinol Metab       Date:  1970-10       Impact factor: 5.958

5.  Growth hormone and cortisol responsiveness in Cushing's syndrome. Relation to a possible central nervous system etiology.

Authors:  D T Krieger; S M Glick
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

6.  Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects.

Authors:  M Sakakura; K Takebe; S Nakagawa
Journal:  J Clin Endocrinol Metab       Date:  1975-05       Impact factor: 5.958

7.  Thyrotrophin and prolactin responsiveness to thyrotrophin releasing hormone in Cushing's disease.

Authors:  S F Kuku; D F Child; S Nader; T R Fraser
Journal:  Clin Endocrinol (Oxf)       Date:  1975-07       Impact factor: 3.478

8.  Reversible gonadotropin deficiency in male Cushing's disease.

Authors:  J P Luton; P Thieblot; J C Valcke; J A Mahoudeau; H Bricaire
Journal:  J Clin Endocrinol Metab       Date:  1977-09       Impact factor: 5.958

9.  Dissociation of prolactin responsiveness to TRH and chlorpromazine in women with isolated gonadotropin deficiency.

Authors:  I M Spitz; U Almaliach; E Rosen; W Polishuk; D Rabinowitz
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

10.  Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man.

Authors:  J R Sowers; H E Carlson; N Brautbar; J M Hershman
Journal:  J Clin Endocrinol Metab       Date:  1977-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.